Stock comparison
Eli Lilly
QuidelOrtho
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LLY
Eli Lilly
Market cap
$1T
Sector
Healthcare
QDEL
QuidelOrtho
Market cap
$808.75M
Sector
Healthcare
Overall winner
Eli Lilly LLY
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LLY | QDEL | Winner |
|---|---|---|---|
| Warren Buffett | 72B | 21F | LLY |
| Benjamin Graham | 86A | 19F | LLY |
| Philip Fisher | 86A | 34F | LLY |
| Peter Lynch | 74B | 36D | LLY |
| Joel Greenblatt | 78C | 0F | LLY |
| Charlie Munger | 85A | 26F | LLY |
| Terry Smith | 77C | 19F | LLY |
Side-by-side metrics
| Metric | LLY | QDEL |
|---|---|---|
| Market cap | $1T | $808.75M |
| P/E (TTM) | 36.6x | - |
| EV/EBIT | 34.1x | - |
| ROIC (TTM) | 32.06% | -19.88% |
| Gross margin | 83.51% | 44.96% |
| Net margin | 34.98% | -45.57% |
| Revenue CAGR 5y | 23.17% | 12.6% |
| EPS CAGR 5y | 40.81% | - |
| Debt / Equity | 1.4x | 1.6x |
| Dividend yield | 0.62% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LLY leads on
- Net margin34.98%vs -45.57%+177%
- ROIC (TTM)32.06%vs -19.88%+162%
- Dividend yield0.62%vs 0.0%+100%
- Market cap$1Tvs $808.75M+100%
QDEL leads on
- EV/EBIT-vs 34.1x+111%
- P/E (TTM)-vs 36.6x+102%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.